ASYMPTOMATIC BACTERIURIA DOES NOT INCREASE THE RISK OF INFECTIVE COMPLICATIONS IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER UNDERGOING INTRAVESICAL BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY

被引:0
|
作者
Nummi, Antti
Nurminen, Pertti
Kesti, Olli
Hogerman, Mikael
Ettala, Otto
Bostrom, Peter
Kaipia, Antti
Sairanen, Jukka
Jarvinen, Riikka
机构
来源
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP08-18
引用
收藏
页码:E101 / E102
页数:2
相关论文
共 50 条
  • [31] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [32] Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer
    Liu, Yuqing
    Lu, Jian
    Huang, Yi
    Ma, Lulin
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [33] Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer: One Size Does Not Fit All
    McKiernan, James
    EUROPEAN UROLOGY, 2016, 70 (05) : 786 - 787
  • [34] Validation of Algorithm to Identify Adequate Intravesical Bacillus Calmette-Guerin Therapy in Non-Muscle-Invasive Bladder Cancer Patients in Administrative Claims
    Chuo, Ching-Yi
    Richard, Kyle A.
    Zivkovic, Marko
    Yi, Jingbo
    Pattipaka, Thirupathi
    Derleth, Christina
    Lin, Shih-Wen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 97 - 97
  • [35] Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
    James, Christopher
    Gomez, Kayeromi
    Desai, Shalin
    Patel, Hiten D.
    Rac, Goran
    Doshi, Chirag P.
    Dornbier, Ryan
    Bajic, Petar
    Halverson, Thomas
    Gupta, Gopal N.
    Quek, Marcus L.
    Gorbonos, Alex
    Flanigan, Robert
    Wolfe, Alan J.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [36] Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guerin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
    McElree, Ian M.
    Steinberg, Ryan L.
    Mott, Sarah L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JAMA NETWORK OPEN, 2023, 6 (02) : e230849
  • [37] Treatment Options Available for Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer
    Yates, David R.
    Brausi, Maurizio A.
    Catto, James W. F.
    Dalbagni, Guido
    Roupret, Morgan
    Shariat, Shahrokh F.
    Sylvester, Richard J.
    Witjes, J. Alfred
    Zlotta, Alexandre R.
    Palou-Redorta, Juan
    EUROPEAN UROLOGY, 2012, 62 (06) : 1088 - 1096
  • [38] Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Alam, Syed M.
    Larson, Matthew
    Srinivasan, Pugazhendhi
    Genz, Nick
    Fleer, Ryan
    Sardiu, Mihaela
    Thompson, Jeffrey
    Lee, Eugene
    Hamilton-Reeves, Jill
    Wulff-Burchfield, Elizabeth
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 431.e15 - 431.e20
  • [39] Replacement Instead of Discontinuation of Bacillus Calmette-Guerin Instillation in Non-Muscle-Invasive Bladder Cancer
    Lin, Po-Ting
    Hung, Wei-Kang
    Chang, Ying-Hsu
    Hsieh, Ming-Li
    Liu, Chung-Yi
    Huang, Liang-Kang
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Lin, Po-Hung
    Yu, Kai-Jie
    Chuang, Cheng-Keng
    Wu, Chun-Te
    Pang, See-Tong
    Shao, I-Hung
    CANCERS, 2023, 15 (04)
  • [40] Bacillus Calmette-Guerin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
    Su, Fei
    Liu, Ming
    Zhang, Wei
    Tang, Min
    Zhang, Jinsong
    Li, Hexin
    Zou, Lihui
    Zhang, Rui
    Liu, Yudong
    Li, Lin
    Ma, Jie
    Zhang, Yaqun
    Chen, Meng
    Xiao, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12